![Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41419-019-2200-2/MediaObjects/41419_2019_2200_Fig1_HTML.png)
Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease
![Voltammetric/UV–Vis study of temozolomide inclusion complexes with cyclodextrin derivatives - ScienceDirect Voltammetric/UV–Vis study of temozolomide inclusion complexes with cyclodextrin derivatives - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1567539419307170-gr1.jpg)
Voltammetric/UV–Vis study of temozolomide inclusion complexes with cyclodextrin derivatives - ScienceDirect
![Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression | Scientific Reports Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep32972/MediaObjects/41598_2016_Article_BFsrep32972_Fig1_HTML.jpg)
Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression | Scientific Reports
![PDF) Successful Pregnancy and Delivery after Concomitant Temozolomide and Radiotherapy Treatment of Glioblastoma Multiforme PDF) Successful Pregnancy and Delivery after Concomitant Temozolomide and Radiotherapy Treatment of Glioblastoma Multiforme](https://i1.rgstatic.net/publication/221980793_Successful_Pregnancy_and_Delivery_after_Concomitant_Temozolomide_and_Radiotherapy_Treatment_of_Glioblastoma_Multiforme/links/5fc65379299bf1a422c81544/largepreview.png)
PDF) Successful Pregnancy and Delivery after Concomitant Temozolomide and Radiotherapy Treatment of Glioblastoma Multiforme
![Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML](https://www.mdpi.com/cells/cells-08-01315/article_deploy/html/images/cells-08-01315-ag-550.jpg)
Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML
![Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML](https://www.mdpi.com/cells/cells-08-01315/article_deploy/html/images/cells-08-01315-g002.png)
Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML
![Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359511321002270-gr4.jpg)
Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect
![Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. - ScienceDirect Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304419X21001141-gr3.jpg)
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. - ScienceDirect
![Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth | Molecular Cancer Therapeutics Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth | Molecular Cancer Therapeutics](https://mct.aacrjournals.org/content/molcanther/14/1/111/F1.large.jpg)
Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth | Molecular Cancer Therapeutics
![Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial - The Lancet Oncology Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/556a9708-0788-4287-b768-d4d33d5709c1/gr1.gif)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial - The Lancet Oncology
![Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth | Molecular Cancer Therapeutics Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth | Molecular Cancer Therapeutics](https://mct.aacrjournals.org/content/molcanther/14/1/111/F3.large.jpg)
Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth | Molecular Cancer Therapeutics
![Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML](https://www.mdpi.com/cells/cells-08-01315/article_deploy/html/images/cells-08-01315-g003.png)
Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML
![Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival | BMC Neurology | Full Text Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival | BMC Neurology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12883-021-02461-9/MediaObjects/12883_2021_2461_Fig1_HTML.png)
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival | BMC Neurology | Full Text
![Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359511321002270-ga1.jpg)
Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect
![Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma | Oncogenesis Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma | Oncogenesis](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Foncsis.2017.31/MediaObjects/41389_2017_Article_BFoncsis201731_Fig1_HTML.jpg)
Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma | Oncogenesis
![Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359511321002270-gr2.jpg)
Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect
![Biomedicines | Free Full-Text | Temozolomide and Other Alkylating Agents in Glioblastoma Therapy | HTML Biomedicines | Free Full-Text | Temozolomide and Other Alkylating Agents in Glioblastoma Therapy | HTML](https://www.mdpi.com/biomedicines/biomedicines-07-00069/article_deploy/html/images/biomedicines-07-00069-g002.png)
Biomedicines | Free Full-Text | Temozolomide and Other Alkylating Agents in Glioblastoma Therapy | HTML
![Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy - ScienceDirect Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365921003461-gr4.jpg)
Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy - ScienceDirect
![PDF) Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival PDF) Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival](https://www.researchgate.net/publication/355857919/figure/fig2/AS:1085927170539591@1635916621946/Overall-survival-curve-for-patients-diagnosed-with-GBM-after-temozolomide-adjuvant_Q320.jpg)
PDF) Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
![Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-019-2200-2/MediaObjects/41419_2019_2200_Fig2_HTML.png)
Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease
![Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma | EMBO Molecular Medicine Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/3070c4d2-39c6-4e17-a1bb-c57f086e21d4/emmm201708492-abs-0001-m.jpg)
Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma | EMBO Molecular Medicine
Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma
![Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival | British Journal of Cancer Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-019-0551-1/MediaObjects/41416_2019_551_Fig1_HTML.png)
Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival | British Journal of Cancer
![Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy - ScienceDirect Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365921003461-gr9.jpg)
Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy - ScienceDirect
![Transcriptional control of O6‐methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma - Happold - 2018 - Journal of Neurochemistry - Wiley Online Library Transcriptional control of O6‐methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma - Happold - 2018 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c5ef20fd-f28a-4803-a365-89b775bcf558/jnc14326-fig-0006-m.png)